title: A two step fractionation approach for plasma proteomics using immunodepletion of abundant proteins and multi-lectin affinity chromatography: Application to the analysis of obesity, diabetes, and hypertension diseases.
abstract: Plasma is an important biological material for biomarker discovery. However, the wide dynamic range in protein concentration remains a major challenge. In this paper, we introduce the development of a proteomic platform for analysis of plasma samples. The method utilizes a double fractionation approach which combines the MARS immunodepletion column with multi-lectin affinity chromatography, M-LAC, to deplete the most abundant proteins in plasma, the majority of which are glycosylated. To determine the suitability of this methodology, we applied the workflow described in this study to a sample set composed of four groups: a control pool and three different disease pools: obesity, diabetes, and hypertension. We were able to identify changes in the level of several proteins; for example, a protein such as angiotensinogen was found to be present at high levels in patients with obesity plus diabetes and hypertension. On the other hand, apolipoprotein CI was shown to be elevated in all disease groups. A review of the literature supported our observation. The methodology presented in this report was shown to be effective for profiling changes in the plasma proteome of subjects with obesity and its associated complications such as diabetes and hypertension.
authors.affiliation: Barnett Institute and Department of Chemistry and Chemical Biology, Northeastern University, Boston, USA.
authors.forename: M K Disni R
authors.initials: MK
authors.lastname: Dayarathna
authors.forename: William S
authors.initials: WS
authors.lastname: Hancock
authors.forename: Marina
authors.initials: M
authors.lastname: Hincapie
mesh_terms: D001798:Blood Proteins / Q000378:metabolism; D002846:Chromatography, Affinity / Q000379:methods*; D002851:Chromatography, High Pressure Liquid; D003920:Diabetes Mellitus / Q000097:blood*; D015536:Down-Regulation; D006801:Humans; D006973:Hypertension / Q000097:blood*; D007118:Immunoassay / Q000379:methods*; D037102:Lectins / Q000378:metabolism*; D009765:Obesity / Q000097:blood*; D010455:Peptides / Q000302:isolation & purification; D040901:Proteomics / Q000379:methods*; D015854:Up-Regulation
chemical_list: D001798:Blood Proteins; D037102:Lectins; D010455:Peptides